Darwin Global Management

Latest statistics and disclosures from Darwin Global Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are INSM, JAZZ, VRNA, GERN, KROS, and represent 99.71% of Darwin Global Management's stock portfolio.
  • Added to shares of these 5 stocks: INSM (+$170M), JAZZ (+$60M), VRNA (+$38M), NRIX, KROS.
  • Started 3 new stock positions in NRIX, VRNA, JAZZ.
  • Reduced shares in these 3 stocks: PCVX (-$251M), GERN (-$44M), SMMT (-$24M).
  • Sold out of its positions in SMMT, PCVX.
  • Darwin Global Management was a net seller of stock by $-46M.
  • Darwin Global Management has $1.1B in assets under management (AUM), dropping by -14.15%.
  • Central Index Key (CIK): 0001839209

Tip: Access up to 7 years of quarterly data

Positions held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Darwin Global Management

Darwin Global Management holds 6 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Insmed Com Par $.01 (INSM) 84.8 $895M +23% 13M 69.04
 View chart
Jazz Pharmaceuticals Shs Usd (JAZZ) 5.7 $60M NEW 485k 123.15
 View chart
Verona Pharma Sponsored Ads (VRNA) 3.6 $38M NEW 810k 46.44
 View chart
Geron Corporation (GERN) 3.2 $34M -56% 9.6M 3.54
 View chart
Keros Therapeutics (KROS) 2.5 $27M +10% 1.7M 15.83
 View chart
Nurix Therapeutics (NRIX) 0.3 $3.1M NEW 164k 18.84
 View chart

Past Filings by Darwin Global Management

SEC 13F filings are viewable for Darwin Global Management going back to 2020